ID

20459

Beschreibung

E-Five Registry: A World-Wide Registry With The Endeavor Zotarolimus Eluting Coronary Stent; ODM derived from: https://clinicaltrials.gov/show/NCT00623441

Link

https://clinicaltrials.gov/show/NCT00623441

Stichworte

Versionen (1)
  1. 23.02.17 23.02.17 -
Hochgeladen am

23. Februar 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Coronary Artery Disease NCT00623441

Englisch

Eligibility Coronary Artery Disease NCT00623441

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient is >18 years of age (or minimum age as required by local regulation)
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
the patient has consented to participate by signing the "patient informed consent form" and/or has authorized the collection and release of his medical information by signing the "patient data release consent form".
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
the patient is suitable for implantation of one or more endeavor(tm) abt-578 eluting coronary stent system in one or more native artery target lesions.
Beschreibung

Drug-eluting coronary stent placement ABT-578 Quantity | Target Lesion Coronary artery Quantity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2609296
UMLS CUI [1,2]
C2350862
UMLS CUI [1,3]
C1265611
UMLS CUI [2,1]
C2986546
UMLS CUI [2,2]
C0205042
UMLS CUI [2,3]
C1265611
lesion length and vessel diameter of the target lesion(s) are according to the "indications for use" as mentioned in the "instructions for use" that comes with every endeavor(tm) abt-578 eluting coronary stent system.
Beschreibung

Target Lesion Length | Target Lesion Vessel Diameter | Drug-Eluting Coronary Stent ABT-578

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2986546
UMLS CUI [1,2]
C1444754
UMLS CUI [2,1]
C2986546
UMLS CUI [2,2]
C0005847
UMLS CUI [2,3]
C1301886
UMLS CUI [3,1]
C1262327
UMLS CUI [3,2]
C2350862
the patient is willing and able to cooperate with registry procedures and required follow up visits.
Beschreibung

Protocol Compliance

Datentyp

boolean

Alias
UMLS CUI [1]
C0525058
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
women with known pregnancy or who are lactating.
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
patients with hypersensitivity or allergies to aspirin, heparin, clopidogrel, ticlopidine, drugs such as abt-578, rapamycin, tacrolimus, sirolimus or similar drugs, or any other analogue or derivative, cobalt, chromium, nickel, molybdenum or contrast media.
Beschreibung

Aspirin allergy | Heparin allergy | Hypersensitivity clopidogrel | Hypersensitivity Ticlopidine | Hypersensitivity ABT-578 | Hypersensitivity Sirolimus | Hypersensitivity Tacrolimus | Hypersensitivity Cobalt | Hypersensitivity Chromium | Allergy to nickel | Hypersensitivity Molybdenum | Contrast media allergy

Datentyp

boolean

Alias
UMLS CUI [1]
C0004058
UMLS CUI [2]
C0571776
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0070166
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0040207
UMLS CUI [5,1]
C0020517
UMLS CUI [5,2]
C2350862
UMLS CUI [6,1]
C0020517
UMLS CUI [6,2]
C0072980
UMLS CUI [7,1]
C0020517
UMLS CUI [7,2]
C0085149
UMLS CUI [8,1]
C0020517
UMLS CUI [8,2]
C0009148
UMLS CUI [9,1]
C0020517
UMLS CUI [9,2]
C0008574
UMLS CUI [10]
C1690547
UMLS CUI [11,1]
C0020517
UMLS CUI [11,2]
C0026402
UMLS CUI [12]
C0570562
patients in whom anti-platelet and/pr anticoagulation therapy is contraindicated.
Beschreibung

Medical contraindication Antiplatelet therapy | Medical contraindication Anticoagulation Therapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C1096021
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0003281
patients who are judged to have a lesion that prevents complete inflation of an angioplasty balloon.
Beschreibung

Lesion Preventing Angioplasty Balloon

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0221198
UMLS CUI [1,2]
C1292733
UMLS CUI [1,3]
C0002996
current medical condition with a life expectancy of less than 12 months.
Beschreibung

medical condition Life Expectancy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0023671
the subject is participating in another device or drug study. subject must have completed the follow-up phase of any previous study at least 30 days prior to enrollment in this trial. the subject may only be enrolled in this e-five registry once.
Beschreibung

Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
UMLS CUI [3]
C2346570
patients with medical conditions that preclude the follow-up as defined in the protocol or that otherwise limits participation in this registry.
Beschreibung

medical condition Exclude Clinical Study Follow-up | medical condition Study Subject Participation Status Limited

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C2828389
UMLS CUI [1,3]
C3274571
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C2348568
UMLS CUI [2,3]
C0439801
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Coronary Artery Disease NCT00623441

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
patient is >18 years of age (or minimum age as required by local regulation)
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
the patient has consented to participate by signing the "patient informed consent form" and/or has authorized the collection and release of his medical information by signing the "patient data release consent form".
boolean
C0021430 (UMLS CUI [1])
Drug-eluting coronary stent placement ABT-578 Quantity | Target Lesion Coronary artery Quantity
Item
the patient is suitable for implantation of one or more endeavor(tm) abt-578 eluting coronary stent system in one or more native artery target lesions.
boolean
C2609296 (UMLS CUI [1,1])
C2350862 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C2986546 (UMLS CUI [2,1])
C0205042 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Target Lesion Length | Target Lesion Vessel Diameter | Drug-Eluting Coronary Stent ABT-578
Item
lesion length and vessel diameter of the target lesion(s) are according to the "indications for use" as mentioned in the "instructions for use" that comes with every endeavor(tm) abt-578 eluting coronary stent system.
boolean
C2986546 (UMLS CUI [1,1])
C1444754 (UMLS CUI [1,2])
C2986546 (UMLS CUI [2,1])
C0005847 (UMLS CUI [2,2])
C1301886 (UMLS CUI [2,3])
C1262327 (UMLS CUI [3,1])
C2350862 (UMLS CUI [3,2])
Protocol Compliance
Item
the patient is willing and able to cooperate with registry procedures and required follow up visits.
boolean
C0525058 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
women with known pregnancy or who are lactating.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Aspirin allergy | Heparin allergy | Hypersensitivity clopidogrel | Hypersensitivity Ticlopidine | Hypersensitivity ABT-578 | Hypersensitivity Sirolimus | Hypersensitivity Tacrolimus | Hypersensitivity Cobalt | Hypersensitivity Chromium | Allergy to nickel | Hypersensitivity Molybdenum | Contrast media allergy
Item
patients with hypersensitivity or allergies to aspirin, heparin, clopidogrel, ticlopidine, drugs such as abt-578, rapamycin, tacrolimus, sirolimus or similar drugs, or any other analogue or derivative, cobalt, chromium, nickel, molybdenum or contrast media.
boolean
C0004058 (UMLS CUI [1])
C0571776 (UMLS CUI [2])
C0020517 (UMLS CUI [3,1])
C0070166 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0040207 (UMLS CUI [4,2])
C0020517 (UMLS CUI [5,1])
C2350862 (UMLS CUI [5,2])
C0020517 (UMLS CUI [6,1])
C0072980 (UMLS CUI [6,2])
C0020517 (UMLS CUI [7,1])
C0085149 (UMLS CUI [7,2])
C0020517 (UMLS CUI [8,1])
C0009148 (UMLS CUI [8,2])
C0020517 (UMLS CUI [9,1])
C0008574 (UMLS CUI [9,2])
C1690547 (UMLS CUI [10])
C0020517 (UMLS CUI [11,1])
C0026402 (UMLS CUI [11,2])
C0570562 (UMLS CUI [12])
Medical contraindication Antiplatelet therapy | Medical contraindication Anticoagulation Therapy
Item
patients in whom anti-platelet and/pr anticoagulation therapy is contraindicated.
boolean
C1301624 (UMLS CUI [1,1])
C1096021 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0003281 (UMLS CUI [2,2])
Lesion Preventing Angioplasty Balloon
Item
patients who are judged to have a lesion that prevents complete inflation of an angioplasty balloon.
boolean
C0221198 (UMLS CUI [1,1])
C1292733 (UMLS CUI [1,2])
C0002996 (UMLS CUI [1,3])
medical condition Life Expectancy
Item
current medical condition with a life expectancy of less than 12 months.
boolean
C3843040 (UMLS CUI [1,1])
C0023671 (UMLS CUI [1,2])
Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device
Item
the subject is participating in another device or drug study. subject must have completed the follow-up phase of any previous study at least 30 days prior to enrollment in this trial. the subject may only be enrolled in this e-five registry once.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C2346570 (UMLS CUI [3])
medical condition Exclude Clinical Study Follow-up | medical condition Study Subject Participation Status Limited
Item
patients with medical conditions that preclude the follow-up as defined in the protocol or that otherwise limits participation in this registry.
boolean
C3843040 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
C3274571 (UMLS CUI [1,3])
C3843040 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C0439801 (UMLS CUI [2,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video